|LETTER TO THE EDITOR
|Year : 2021 | Volume
| Issue : 2 | Page : 576
Effect of COVID-19 outbreak on community screening program for cancer prevention: A note from endemic area of cholangiocarcinoma
Sora Yasri1, Viroj Wiwanitkit2
1 Private Academic Consultant, Bangkok, Thailand
2 Department of Community Medicine, Dr Dy Patil University, Pune, Maharashtra, India; Department of Biological Science, Joseph Ayobabalola University, Ikeji-Arakeji, Osun State, Nigeria
|Date of Submission||26-Nov-2020|
|Date of Decision||15-Dec-2020|
|Date of Acceptance||03-Jan-2021|
|Date of Web Publication||11-Jun-2021|
Private Academic Consultant, Bangkok
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Yasri S, Wiwanitkit V. Effect of COVID-19 outbreak on community screening program for cancer prevention: A note from endemic area of cholangiocarcinoma. J Can Res Ther 2021;17:576
|How to cite this URL:|
Yasri S, Wiwanitkit V. Effect of COVID-19 outbreak on community screening program for cancer prevention: A note from endemic area of cholangiocarcinoma. J Can Res Ther [serial online] 2021 [cited 2021 Oct 20];17:576. Available from: https://www.cancerjournal.net/text.asp?2021/17/2/576/318109
The COVID-19 pandemic causes several problems worldwide. The effect of outbreak on local public health system is noted. In oncology, the effect of COVID-19 on cancer prevention is interesting. Nevertheless, there are limited reports on this issue. Here, the authors discuss on the effect of COVID-19 outbreak on community screening program for cancer prevention with specific referencing to situation in an endemic area of cholangiocarcinoma, Thailand. In the mentioned setting, there is an extremely high incidence of cholangiocarcinoma. The local public health policies for managing the cancer include the active case screening using abdominal ultrasonography screening. In Thailand, there will be a local indicator for complete active cancer screening coverage of target population. The bench marking is 100% each local public health budget year (an October to next October).
In year 2020, Indochina is the second area of the world affected by COVID-19. The disease has been occurred since January 2020. Here, the authors retrospectively analyzed the data on coverage of cholangiocarcinoma screening in six different regions of Thailand that are endemic areas of the cancer. According to the local registry data for budget year 2020, from overall 58,000 target cases, the screening is complete in only 4127 cases (7.1%). The coverage rate is very low. This is a negative effect of the COVID-19 pandemic on the cancer prevention activity.
The low coverage might be because ultrasonography screening for cholangiocarcinoma requires a closed contact. The screening might not applicable during the COVID-19 break since it might confer a risk and not according to social distancing concept. Specific adaptation for cancer screening activity during COVID-19 is required and should be the topic for further research in preventive oncology.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| > References|| |
Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet 2014;383:2168-79.
Sungkasubun P, Siripongsakun S, Akkarachinorate K, Vidhyarkorn S, Worakitsitisatorn A, Sricharunrat T, et al
. Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: A population-based prospective study of 4,225 subjects in an endemic area. BMC Cancer 2016;16:346.